Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity Surgery
Condition: Obesity Interventions: Drug: Naltrexone/bupropion; Other: Lifestyle Sponsors: Oslo University Hospital; Orexigen Therapeutics, Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bupropion | Eating Disorders & Weight Management | Hospitals | Obesity | Research | Wellbutrin